Back to User profile » Prof. Dr. Lei Liu
Papers published by Prof. Dr. Lei Liu:
Efficacy and Safety of Rituximab in Treating Adult Patients with Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Prospective Study Compared with Glucocorticoids
Zhao YX, Li X, Cheng X, Pan Y, Liu L
Drug Design, Development and Therapy 2025, 19:10571-10587
Published Date: 27 November 2025
Inhibition of Caspase-3/GSDME Pathway-Mediated Pyroptosis of Renal Tubular Epithelial Cells by Dagliflozin in the Pathogenesis of Diabetic Kidney Disease and Study of Its Mechanism
Jiang H, Gao M, Liu J, Yang L, Liu L
Diabetes, Metabolic Syndrome and Obesity 2025, 18:1903-1914
Published Date: 10 June 2025
Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China
Pan Y, Chen WD, Liu L, Yang H, Chang B, Cui C
ImmunoTargets and Therapy 2024, 13:385-398
Published Date: 25 July 2024
Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway
Pan Y, Liu L, Yang H, Chen W, Chen Z, Xu J
Diabetes, Metabolic Syndrome and Obesity 2022, 15:2479-2488
Published Date: 13 August 2022
Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
Wu X, Liu L, Guo Y, Yang L
International Journal of Nephrology and Renovascular Disease 2018, 11:241-247
Published Date: 20 September 2018
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L
Vascular Health and Risk Management 2018, 14:103-108
Published Date: 29 May 2018
